house · trading 2023-02-06 → 2023-02-06
*Notional-weighted price return on disclosed buys, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2023-02-06 | GSK | SELL | $1K–$15K | $35.34 | $52.50 2026-06-26 | -48.6% exit |
| 2023-02-06 | F | BUY | $1K–$15K | $13.14 | $14.13 2026-06-26 | +7.5% |
| 2023-02-06 | CCL | SELL | $1K–$15K | $11.87 | $29.07 2026-06-26 | -144.9% exit |
| 2023-02-06 | AMZN | SELL | $1K–$15K | $102.18 | $232.69 2026-06-26 | -127.7% exit |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Hon. James B. Renacci | 3 · AMZN, CCL, GSK |
| Hon. Kenny Marchant | 3 · AMZN, F, GSK |
| Thomas H Tuberville | 3 · CCL, F, GSK |
| Hon. Mike Kelly | 3 · AMZN, F, GSK |
| Hon. David P. Roe | 3 · AMZN, F, GSK |
| Hon. K. Michael Conaway | 3 · AMZN, F, GSK |
| Hon. Josh Gottheimer | 3 · AMZN, CCL, F |
| Hon. E. Scott Rigell | 3 · CCL, F, GSK |
| Hon. Marie Newman | 3 · AMZN, CCL, F |
| PAT ROBERTS | 2 · AMZN, F |
| Hon. Virginia Foxx | 2 · F, GSK |
| Hon. Kurt Schrader | 2 · AMZN, GSK |